Welcome to LookChem.com Sign In|Join Free
  • or
3-(2-tert-butoxy-2-oxoethoxy)benzoic acid, also known as Diclofenac, is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily used to alleviate pain and inflammation associated with various conditions, such as arthritis. It functions by inhibiting the production of prostaglandins, which are the body's chemicals responsible for causing pain and inflammation.

313709-63-6

Post Buying Request

313709-63-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

313709-63-6 Usage

Uses

Used in Pharmaceutical Industry:
3-(2-tert-butoxy-2-oxoethoxy)benzoic acid is used as an analgesic and anti-inflammatory agent for the treatment of conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is effective in reducing pain and inflammation, providing relief to patients suffering from these conditions.
Used in Pain Management:
3-(2-tert-butoxy-2-oxoethoxy)benzoic acid is used as a pain reliever for various types of pain, including acute and chronic pain. It is particularly useful for conditions that involve inflammation, such as sprains, strains, and postoperative pain.
Used in Topical Applications:
3-(2-tert-butoxy-2-oxoethoxy)benzoic acid is used in the form of topical gels for localized pain and inflammation relief. This allows for targeted treatment and reduces the risk of systemic side effects associated with oral administration.
Used in Oral Administration:
3-(2-tert-butoxy-2-oxoethoxy)benzoic acid is used in the form of oral tablets for systemic pain and inflammation relief. This mode of administration allows for broader distribution of the drug throughout the body, providing relief for conditions that affect multiple joints or areas.
Used in Parenteral Administration:
In some cases, 3-(2-tert-butoxy-2-oxoethoxy)benzoic acid is used as an injection for rapid relief of severe pain and inflammation. This method of administration provides immediate access to the drug, offering quick relief for patients in need.
It is crucial to use 3-(2-tert-butoxy-2-oxoethoxy)benzoic acid under the guidance of a healthcare professional to ensure safe and effective treatment, as it can have potential side effects and interactions with other medications.

Check Digit Verification of cas no

The CAS Registry Mumber 313709-63-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,7,0 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 313709-63:
(8*3)+(7*1)+(6*3)+(5*7)+(4*0)+(3*9)+(2*6)+(1*3)=126
126 % 10 = 6
So 313709-63-6 is a valid CAS Registry Number.

313709-63-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]benzoic acid

1.2 Other means of identification

Product number -
Other names 3-Carboxyphenoxyacetic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:313709-63-6 SDS

313709-63-6Relevant academic research and scientific papers

Aminodeoxychorismate synthase inhibitors from one-bead one-compound combinatorial libraries: "Staged" inhibitor design

Dixon, Seth,Ziebart, Kristin T.,He, Ze,Jeddeloh, Melissa,Yoo, Choong Leol,Wang, Xiaobing,Lehman, Alan,Lam, Kit S.,Toney, Michael D.,Kurth, Mark J.

, p. 7413 - 7426 (2007/10/03)

4-Amino-4-deoxychorismate synthase (ADCS) catalyzes the first step in the conversion of chorismate into p-aminobenzoate, which is incorporated into folic acid. We aim to discover compounds that inhibit ADCS and serve as leads for a new class of antimicrobial compounds. This report presents (1) synthesis of a mass-tag encoded library based on a "staged" design, (2) massively parallel fluorescence-based on-bead screening, (3) rapid structural identification of hits, and (4) full kinetic analysis of ADCS. All inhibitors are competitive against chorismate and Mg2+. The most potent ADCS inhibitor identified has a Ki of 360 μM. We show that the combinatorial diversity elements add substantial binding affinity by interacting with residues outside of but proximal to the active site. The methods presented here constitute a paradigm for inhibitor discovery through active site targeting, enabled by rapid library synthesis, facile massively parallel screening, and straightforward hit identification.

Chemical compounds

-

, (2008/06/13)

The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 313709-63-6